Amplifon owner overcomes complexities to raise €133m

Ampliter, an unlisted holding company, raised €135m through a 2018 bond exchangeable into Amplifon, an Italian-based hearing aid manufacturer, on Tuesday. A complex corporate organisation was matched by an equally complicated deal structure, but strong demand in the equity-linked market helped the deal price aggressively.

  • By Andrew Griffin
  • 08 Nov 2013
Amplifin, the parent company, owns a real estate business, and 100% of the shares of Ampliter, a Dutch holding company. Ampliter owns 54.3% of Amplifon, the world's leading hearing aid manufacturer, as well as a €4m loan that will be repaid using the proceeds from the deal. The ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 358,291.38 1348 9.06%
2 JPMorgan 320,704.66 1461 8.11%
3 Bank of America Merrill Lynch 318,128.31 1104 8.04%
4 Goldman Sachs 236,643.87 789 5.98%
5 Barclays 231,197.41 895 5.84%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 HSBC 35,007.57 165 6.53%
2 Deutsche Bank 34,880.53 120 6.51%
3 Bank of America Merrill Lynch 31,805.65 97 5.93%
4 BNP Paribas 27,920.60 169 5.21%
5 SG Corporate & Investment Banking 24,398.89 138 4.55%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 19,745.92 80 8.85%
2 Morgan Stanley 16,334.63 83 7.32%
3 Citi 15,972.34 95 7.16%
4 UBS 15,487.17 60 6.94%
5 Goldman Sachs 14,053.61 76 6.30%